Vanguard Group Inc. Has $63.30 Million Stock Position in Alignment Healthcare, Inc. (NASDAQ:ALHC)

Vanguard Group Inc. increased its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 3.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,121,432 shares of the company's stock after buying an additional 322,661 shares during the quarter. Vanguard Group Inc. owned 4.82% of Alignment Healthcare worth $63,303,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Price T Rowe Associates Inc. MD raised its holdings in shares of Alignment Healthcare by 2.8% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 8,805,887 shares of the company's stock valued at $100,475,000 after acquiring an additional 236,652 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in shares of Alignment Healthcare by 15.1% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 8,470,181 shares of the company's stock valued at $99,610,000 after purchasing an additional 1,108,973 shares during the period. Durable Capital Partners LP lifted its stake in shares of Alignment Healthcare by 2,079.2% in the 1st quarter. Durable Capital Partners LP now owns 5,908,220 shares of the company's stock valued at $66,349,000 after purchasing an additional 5,637,102 shares during the period. BlackRock Inc. lifted its stake in shares of Alignment Healthcare by 21.8% in the 3rd quarter. BlackRock Inc. now owns 5,698,621 shares of the company's stock valued at $67,471,000 after purchasing an additional 1,020,637 shares during the period. Finally, Deerfield Management Company L.P. Series C raised its stake in Alignment Healthcare by 49.1% during the third quarter. Deerfield Management Company L.P. Series C now owns 2,747,015 shares of the company's stock valued at $19,064,000 after buying an additional 905,015 shares during the last quarter. Institutional investors own 86.19% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on ALHC. Stephens lifted their price objective on Alignment Healthcare from $10.00 to $10.50 and gave the stock an "equal weight" rating in a report on Tuesday, January 9th. Stifel Nicolaus initiated coverage on Alignment Healthcare in a research note on Wednesday, January 24th. They set a "buy" rating and a $11.00 price target for the company. Piper Sandler reissued a "neutral" rating and set a $6.00 price target (down from $12.00) on shares of Alignment Healthcare in a research note on Wednesday, March 6th. William Blair reissued an "outperform" rating on shares of Alignment Healthcare in a research note on Wednesday, March 6th. Finally, UBS Group dropped their price target on Alignment Healthcare from $9.00 to $8.50 and set a "neutral" rating for the company in a research note on Wednesday, February 28th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $9.61.

Insider Buying and Selling

In other Alignment Healthcare news, insider Dawn Christine Maroney sold 23,000 shares of the firm's stock in a transaction on Friday, March 8th. The stock was sold at an average price of $5.44, for a total transaction of $125,120.00. Following the transaction, the insider now directly owns 1,830,008 shares in the company, valued at approximately $9,955,243.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Alignment Healthcare news, CFO Robert Thomas Freeman sold 11,858 shares of the firm's stock in a transaction on Friday, March 15th. The stock was sold at an average price of $4.89, for a total transaction of $57,985.62. Following the transaction, the chief financial officer now directly owns 898,228 shares in the company, valued at approximately $4,392,334.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Dawn Christine Maroney sold 23,000 shares of the firm's stock in a transaction on Friday, March 8th. The stock was sold at an average price of $5.44, for a total value of $125,120.00. Following the transaction, the insider now owns 1,830,008 shares in the company, valued at $9,955,243.52. The disclosure for this sale can be found here. In the last three months, insiders sold 90,213 shares of company stock valued at $460,587. Insiders own 6.30% of the company's stock.

Alignment Healthcare Trading Up 2.3 %

Shares of ALHC stock traded up $0.11 on Monday, reaching $4.80. 555,990 shares of the company's stock were exchanged, compared to its average volume of 893,883. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $9.20. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 1.02. The stock has a market capitalization of $907.09 million, a PE ratio of -6.08 and a beta of 1.30. The company's fifty day simple moving average is $5.66 and its 200 day simple moving average is $6.79.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings results on Tuesday, February 27th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.22) by ($0.03). Alignment Healthcare had a negative return on equity of 75.64% and a negative net margin of 8.12%. The business had revenue of $465.39 million for the quarter, compared to the consensus estimate of $444.56 million. During the same period in the prior year, the business posted ($0.31) earnings per share. Alignment Healthcare's revenue was up 28.6% on a year-over-year basis. As a group, analysts forecast that Alignment Healthcare, Inc. will post -0.59 EPS for the current year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.